These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 8195722)

  • 1. Resting and activated T cells display different requirements for CD8 molecules.
    Cai Z; Sprent J
    J Exp Med; 1994 Jun; 179(6):2005-15. PubMed ID: 8195722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.
    Utting O; Teh SJ; Teh HS
    J Immunol; 1998 Jun; 160(11):5410-9. PubMed ID: 9605142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
    de Vries JE; Yssel H; Spits H
    Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules.
    Wiest DL; Yuan L; Jefferson J; Benveniste P; Tsokos M; Klausner RD; Glimcher LH; Samelson LE; Singer A
    J Exp Med; 1993 Nov; 178(5):1701-12. PubMed ID: 8228817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune deviation of 2C transgenic intraepithelial lymphocytes in antigen-bearing hosts.
    Guehler SR; Bluestone JA; Barrett TA
    J Exp Med; 1996 Aug; 184(2):493-503. PubMed ID: 8760803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.
    Cawthon AG; Alexander-Miller MA
    J Immunol; 2002 Oct; 169(7):3492-8. PubMed ID: 12244138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic selection of cytotoxic T cells independent of CD8 alpha-Lck association.
    Chan IT; Limmer A; Louie MC; Bullock ED; Fung-Leung WP; Mak TW; Loh DY
    Science; 1993 Sep; 261(5128):1581-4. PubMed ID: 8372352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of functional heterogeneity in the CD8 subset with T cells from T cell receptor-transgenic mice.
    Gaugler B; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1993 Aug; 23(8):1851-8. PubMed ID: 8344346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.
    Cai Z; Sprent J
    J Exp Med; 1996 May; 183(5):2247-57. PubMed ID: 8642334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for differential intracellular signaling via CD4 and CD8 molecules.
    Ravichandran KS; Burakoff SJ
    J Exp Med; 1994 Feb; 179(2):727-32. PubMed ID: 8294879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threshold tolerance in H-2Kb-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent to helper-dependent CTL.
    Auphan N; Jézo-Brémond A; Schönrich G; Hämmerling G; Arnold B; Malissen B; Schmitt-Verhulst AM
    Int Immunol; 1992 Dec; 4(12):1419-28. PubMed ID: 1286065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.
    De Lau WB; Boom SE; Heije K; Griffioen AW; Braakman E; Bolhuis RL; Tax WJ; Clevers H; Bast BJ
    J Immunol; 1992 Sep; 149(6):1840-6. PubMed ID: 1387662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.
    Nugent CT; Morgan DJ; Biggs JA; Ko A; Pilip IM; Pamer EG; Sherman LA
    J Immunol; 2000 Jan; 164(1):191-200. PubMed ID: 10605011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.